184 related articles for article (PubMed ID: 32901806)
21. Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Yaro JB; Ouedraogo A; Diarra A; Sombié S; Ouedraogo ZA; Nébié I; Drakeley C; Sirima SB; Tiono AB; Lindsay SW; Wilson AL
Malar J; 2021 Sep; 20(1):362. PubMed ID: 34488770
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
[TBL] [Abstract][Full Text] [Related]
23. Frequencies of dhfr/dhps multiple mutations and Plasmodium falciparum submicroscopic gametocyte carriage in Gabonese pregnant women following IPTp-SP implementation.
Bouyou-Akotet MK; Tshibola ML; Mawili-Mboumba DP; Nzong J; Bahamontes-Rosa N; Tsoumbou-Bakana G; Kombila M
Acta Parasitol; 2015 Jun; 60(2):218-25. PubMed ID: 26203988
[TBL] [Abstract][Full Text] [Related]
24. Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study.
Unger HW; Rosanas-Urgell A; Robinson LJ; Ome-Kaius M; Jally S; Umbers AJ; Pomat W; Mueller I; Kattenberg E; Rogerson SJ
Malar J; 2019 Sep; 18(1):302. PubMed ID: 31477117
[TBL] [Abstract][Full Text] [Related]
25. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK
Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125
[TBL] [Abstract][Full Text] [Related]
26. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
[TBL] [Abstract][Full Text] [Related]
27. Malaria Infection Is Common and Associated With Perinatal Mortality and Preterm Delivery Despite Widespread Use of Chemoprevention in Mali: An Observational Study 2010 to 2014.
Mahamar A; Andemel N; Swihart B; Sidibe Y; Gaoussou S; Barry A; Traore M; Attaher O; Dembele AB; Diarra BS; Keita S; Dicko A; Duffy PE; Fried M
Clin Infect Dis; 2021 Oct; 73(8):1355-1361. PubMed ID: 33846719
[TBL] [Abstract][Full Text] [Related]
28. Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi.
Taylor SM; Levitt B; Freedman B; Madanitsa M; Thwai KL; Kalilani-Phiri L; Khairallah C; Mwapasa V; Ter Kuile FO; Meshnick SR
J Infect Dis; 2020 Jul; 222(4):661-669. PubMed ID: 32221555
[TBL] [Abstract][Full Text] [Related]
29. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
[TBL] [Abstract][Full Text] [Related]
30. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
COSMIC Consortium
Clin Infect Dis; 2019 Feb; 68(4):586-596. PubMed ID: 29961848
[TBL] [Abstract][Full Text] [Related]
31. Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
Huijben S; Macete E; Mombo-Ngoma G; Ramharter M; Kariuki S; Desai M; Shi YP; Mwangoka G; Massougbodji A; Cot M; Ndam NT; Uberegui E; Gupta H; Cisteró P; Aponte JJ; González R; Menéndez C; Mayor A
J Infect Dis; 2020 Jan; 221(2):293-303. PubMed ID: 31677349
[TBL] [Abstract][Full Text] [Related]
32. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
Tutu EO; Lawson B; Browne E
Malar J; 2011 Dec; 10():385. PubMed ID: 22206597
[TBL] [Abstract][Full Text] [Related]
33. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
Walker PG; Floyd J; Ter Kuile F; Cairns M
PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
[TBL] [Abstract][Full Text] [Related]
34. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
[TBL] [Abstract][Full Text] [Related]
36. The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens.
Waltmann A; McQuade ETR; Chinkhumba J; Operario DJ; Mzembe E; Itoh M; Kayange M; Puerto-Meredith SM; Mathanga DP; Juliano JJ; Carroll I; Bartelt LA; Gutman JR; Meshnick SR
EBioMedicine; 2022 Mar; 77():103871. PubMed ID: 35217408
[TBL] [Abstract][Full Text] [Related]
37. Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.
Desai M; Gutman J; Taylor SM; Wiegand RE; Khairallah C; Kayentao K; Ouma P; Coulibaly SO; Kalilani L; Mace KE; Arinaitwe E; Mathanga DP; Doumbo O; Otieno K; Edgar D; Chaluluka E; Kamuliwo M; Ades V; Skarbinski J; Shi YP; Magnussen P; Meshnick S; Ter Kuile FO
Clin Infect Dis; 2016 Feb; 62(3):323-333. PubMed ID: 26486699
[TBL] [Abstract][Full Text] [Related]
38. Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.
Le Port A; Cottrell G; Dechavanne C; Briand V; Bouraima A; Guerra J; Choudat I; Massougbodji A; Fayomi B; Migot-Nabias F; Garcia A; Cot M
Am J Trop Med Hyg; 2011 Feb; 84(2):270-5. PubMed ID: 21292898
[TBL] [Abstract][Full Text] [Related]
39. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
[TBL] [Abstract][Full Text] [Related]
40. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
Chaponda EB; Mharakurwa S; Michelo C; Bruce J; Chandramoha D; Matthew Chico R
Malar J; 2021 Jan; 20(1):61. PubMed ID: 33482823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
